Phase I clinical development of PPMX-T003 for polycythemia vera
A standalone drug development program for PPMX-T003 that, following completion of a Phase I trial in healthy subjects, moves to dosing patients with polycythemia vera and advances a domestic Phase I trial.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.